---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-061445"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2026-09-10T23:24:47+00:00"
generated_at: "2026-09-11T10:05:29.917582+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vistagen shareholders elect board, back say-on-pay and KPMG at annual meeting

## Summary
- All four director nominees elected: Saxe, Cunningham, Williamson, Singh; Cunningham and Singh saw narrower support (4.66M/3.83M and 4.97M/3.53M).
- Say-on-pay advisory vote approved: 6,625,045 for, 1,142,430 against, 729,413 abstentions.
- KPMG LLP ratification approved as FY2027 auditor: 22,495,649 for, 680,897 against, 685,683 abstentions.

## SEC filing metadata
- accession: 0001628280-26-061445
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2026-09-10T23:24:47+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/0001628280-26-061445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/vtgn-20260910.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-061445
- JSON: https://secwatch.observer/filing/0001628280-26-061445.json
- Plain text: https://secwatch.observer/filing/0001628280-26-061445.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.